Curcumin has been reported to inhibit inflammation, tumor growth, angiogenesis and metastasis by decreasing cell growth and by inducing apoptosis mainly through the inhibition of nuclear factor kappa-B (NFκB), a master regulator of inflammation. Recent reports also indicate potential metabolic effects of the polyphenol, therefore we analyzed whether and how it affects the energy metabolism of tumor cells. We show that curcumin (10 µM) inhibits the activity of ATP synthase in isolated mitochondrial membranes leading to a dramatic drop of ATP and a reduction of oxygen consumption in in vitro and in vivo tumor models. The effects of curcumin on ATP synthase are independent of the inhibition of NFκB since the IκB Kinase inhibitor, SC-514, does not affect ATP synthase. The activities of the glycolytic enzymes hexokinase, phosphofructokinase, pyruvate kinase and lactate dehydrogenase are only slightly affected in a cell type-specific manner. The energy impairment translates into decreased tumor cell viability. Moreover, curcumin induces apoptosis by promoting the generation of reactive oxygen species (ROS) and malondialdehyde (MDA), a marker of lipid oxidation, and autophagy, at least in part due to the activation of the AMP-activated protein kinase (AMPK). According to the in vitro anti-tumor effect, curcumin (30 mg/kg body weight) significantly delayed in vivo cancer growth likely due to an energy impairment but also through the reduction of tumor angiogenesis. These results establish the ATP synthase, a central enzyme of the cellular energy metabolism, as a target of the antitumoral polyphenol leading to inhibition of cancer cell growth and a general reprogramming of tumor metabolism.
Introduction
Curcumin (diferuloylmethane; (1E,6E)-1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a polyphenol isolated from the zingiberaceae Curcuma longa. It is used as a spice and forms the basic, yellow ingredient of curry. In recent years, many studies have reported antitumoral activities of curcumin (for reviews see (1) (2) (3) ) even for solid cancers after dietary administration (4) (5) (6) , despite the reduced bioavailability, poor absorption, rapid metabolism, rapid systemic elimination (7) and the low levels detectable in the blood of curcumin-treated patients (8) . Curcumin and its derivatives and analogs have been reported to act by influencing many cell signaling pathways (1) , but the inhibition of the IκB kinase (IkK), leading to the stabilization in the dephosphorylated state of the inhibitor of nuclear factor kappa B (IκB) and the sequestration of NFκB in its inactive form in the cytoplasm, appears as the main activity of the polyphenol (9, 10) . Recent works also reveal its potential as a regulator of metabolism (11) (12) (13) (14) (15) (16) (17) , an activity that has been linked to the reduction of inflammation and inhibition of NFκB. However, little attention has been paid to eventual effects of curcumin and other polyphenols on energy metabolism of the cancer cell.
Tumor growth requires increased synthesis of the building blocks of the cell such as nucleotides, amino acids and lipids. Tumor cells therefore deploy a metabolism typical of proliferating cells, which must satisfy three metabolic demands: (i) bioenergetics, (ii) macromolecular biosynthesis and (iii) redox maintenance. As a consequence, cancer cell metabolism is characterized by an increased uptake of glucose that is preferentially metabolized to lactate through aerobic glycolysis (Warburg effect) , although this process is less efficient in terms of ATP generation in comparison to the oxidative phosphorylation. However, the preferential catabolism of glucose to lactate allows tumor cells to shunt various glycolytic intermediates into anabolic pathways that support proliferation (18) (19) (20) . Short term starvation and fasting mimicking diet revert the Warburg effect in tumor cells leading to their apoptosis (21) , sensitize tumor cells to chemotherapy (22, 23) and enhance antitumoral immune surveillance (24, 25) thereby protecting normal cell function. Interestingly, polyphenols like curcumin and the green tea derived compound epigallocatechin-3-gallate appear to trigger the same molecular pathways that usually are elicited by long-term caloric restriction or short-term starvation (26, 27) .
Hence, if curcumin has the potential to mimic these effects of fasting, it is expected to have major effects on tumor metabolism. The potential of the polyphenols to counteract the development of metabolic syndrome has been established, although systematic clinical studies have not been performed (28) . Curcumin has been shown to reduce hematic glucose levels through the induction of the AMP-activated kinase (AMPK) (29) and to block tumor necrosis factor α (TNFα)-induced glycolysis in breast cancer cells (14) . This latter effect is exerted through the anti-inflammatory, anti-NFκB activity of curcumin. Bayet-Robert and coworkers performed a metabolomic study on curcumin treated breast cancer cells and identified the glutathione and lipid metabolism as well as glucose utilization as major targets of the polyphenol. Glutathione biosynthesis was upregulated in response to the increase of reactive oxygen species (ROS) induced by curcumin. The activity on lipid metabolism was likely linked to the effects of the compound on the NFκB pathway (15) . Curcumin (30, 31) and other polyphenols (32) affect the function of mitochondria likely through the generation of ROS (33) (34) (35) (36) , but little attention has been paid to the effect of these compounds on mitochondrial energy metabolism. Inhibition of the mitochondrial ATP-synthase activity of normal tissues has been shown for several polyphenols (37) including curcumin that exerted, however, tissue-dependent effects (38) . For the bacterial ATP synthase, inhibition by curcumin follows a unique mechanism involving rotation cycles of the F1 moiety (39, 40) . It is therefore highly likely that curcumin exerts similar effects on the eukaryotic ATP synthase with major effects on cellular energy metabolism.
We have addressed this issue through the analysis of the effects of curcumin on energy metabolism in cancer cells. We show that curcumin inhibits the ATP-synthase activity thereby influencing the ATP/AMP ratio and oxygen consumption, which in turn lead to reduced cell viability, increased ROS production, apoptosis and autophagy. The inhibition of the ATP synthase by curcumin persists in vivo where it is accompanied by diminished tumor angiogenesis leading to reduced tumor growth. The effect on ATP-synthase is NFκB independent.
Materials and methods

Chemicals
Curcumin (GmbH & Co KG, Karlsruhe, Germany) was dissolved in dimethyl sulfoxide (DMSO; Sigma Aldrich, St. Louis, MO) at a final concentration of 100 mM and stored at −20°C until used. For in vitro experiments, it was diluted in complete medium, immediately before use. Active concentrations were determined in preliminary in vitro experiments on B16 cells (Supplementary Figure 2 , available at Carcinogenesis Online). For in vivo experiments following the protocol described by Pisano et al. (41) rising the dosage to 30 mg/kg body weight. Curcumin was diluted in a sterile 0.9% (w/v) NaCl solution containing 1.65 mg/ml bovine serum albumin (BSA, Sigma, St. Louis, MO). Curcumin dilutions were freshly prepared immediately before injection and protected from light.
Cell lines and culture conditions
L1210 murine lymphocytic leukemia, 4T1 murine breast, B16 murine melanoma and CT26 murine colon tumor cell lines were purchased by ATCC on 16/03/2016 and authenticated by microsatellite analysis at the Italian Cell Line Collection (LGC Standards S.r.l, Sesto San Giovanni, MI, Italy). All tumor cell lines were cultured in DMEM medium (Euroclone, Milan, Italy) supplemented with 1% L-glutamine, 1% penicillin/streptomycin and 10% fetal bovine serum (all from Sigma Aldrich) (complete medium).
Evaluation of cell viability, apoptosis and autophagy
Tumor cell lines were plated in 12-well plates (Falcon, Becton Dickinson, Le Pont de Claix, France) (CT26 and 4T1 1 × 10 5 , B16 3 × 10 4 , L1210 2 × 10 5 per well) in complete medium. After 24 h, the cells were treated with curcumin at 10 µM for 24 h. Then the cells were harvested and the number was assessed by Trypan blue (Sigma Aldrich) exclusion assay. In some experiments, the cells were co-incubated with the specific IKKβ inhibitor SC-514 (Selleckchem, Munich, Germany) at 10µM ± curcumin for 4 and 24 h. Apoptosis was evaluated by the Annexin V-FITC Apoptosis Detection Kit (eBioscience, Milan, Italy) according to the manufacturer's instructions. For autophagy analysis, B16 melanoma cells were transfected by Lipofectamine 2000 with 750ng pEX-HcRed-hLC3WT plasmid (Addgene plasmid 24991 (42)), encoding for the LC3B protein fused to the HcRed fluorescent protein (Invitrogen, Monza, Italy). After 72 h, all the differently treated samples were fixed with MetOH/acetone 1:1 ratio, washed with phosphate-buffered saline solution (Sigma), then fixed with Prolong Gold Antifade reagent (Invitrogen) and counterstained with 4,6-diamidino-2-phenylindole (DAPI; Roche, Basilea, Switzerland) for nuclei identification.
Quantification of LC3B dots was performed by fluorescence microscopy (Zeiss, Oberkochen, Germany) and images were acquired with a Nikon camera and the ACT-2U image software. Each experiment was repeated two times and at least 50 transfected cells were analyzed. Images were acquired by using 100× magnification objectives (Zeiss).
ROS generation assay
Tumor cells were seeded into 12-well plates and treated as described above. Cells were stained with 1 µM oxidative sensitive dye 2ʹ,7ʹ-dichlorofluorescein diacetate (DCFDA, Invitrogen) in phosphate-buffered saline for 30 
Evaluation of ATP and AMP levels
ATP and AMP were measured according to the enzyme coupling method, following NAD(P)/NADP)H reduction/oxidation at 340 nm. ATP quantification assay was conducted in a medium containing: 100 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 50 mM glucose, 0.2 mM NADP. The assay started after the addition of 4 µg of purified hexokinase and 2 µg of glucose-6-phosphate dehydrogenase. AMP concentration was assayed using the following medium: 100 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 10 mM phosphoenolpyruvate, 0.15 mM NADH, 0.2 mM ATP. The assay started after the addition of 4 µg of purified pyruvate kinase plus lactate dehydrogenase and 2 µg of adenylate kinase (45) .
Evaluation of lactate release
The lactate concentration was measured in the growth medium, following the reduction of NAD + . The assay mixture contained: 100mM Tris-HCl pH 7.4, 5 mM NAD + and 4IU of lactate dehydrogenase. Data are normalized on the number of cells (21) .
Evaluation of mitochondrial membrane potential
To evaluate the mitochondrial membrane potential of different tumor cell lines, 250 nM Mitotracker 633 (MT633) was added to the growth medium, monitoring the fluorescence every 10 min for 60 min, in a plate reader (Infinite 200, Tecan, Mannedorf, Switzerland), using 644 and 665 nm as excitation and emission wavelengths, respectively (46) .
Glycolytic enzyme assays
Enzymatic activity was expressed as IU/mg of total protein (micromoles/ min/mg of protein). The assays were conducted on 50 µg of total protein. The reaction mixtures used for the determination of each enzyme activity were prepared as follows (47) . Hexokinase (HK, EC 2.7.1.1): 100 mM Tris-HCl pH 7.4, 5 mM MgCl 2 , 200 mM glucose, 1 mM ATP, 0.91 mM NADP and 0.55 IU/ml of glucose-6-phosphate dehydrogenase (G6PD). Phosphofructokinase (PFK, EC 2.7.1.11): 100 mM Tris-HCl pH 7.4, 2 mM MgCl 2 , 5 mM KCl, 2 mM fructose 6 phosphate, 1 mM ATP, 0.5 mM phosphoenolpyruvate (PEP), 0.2 mM NADH and 2 IU/ml of pyruvate kinase plus lactate dehydrogenase. Pyruvate kinase (PK, EC 2.7.1.40): 100 mM Tris-HCl pH 7.6, 2.5 mM MgCl 2 , 10 mM KCl, 0.6mM phosphoenolpyruvate, 0.2 mM NADH, 5 mM ADP and 1 IU/ml of lactate dehydrogenase. Lactate dehydrogenase (LDH, EC 1.1.1.27): 100 mM Tris-HCl pH 9, 5 mM pyruvate and 0.2 mM NADH (43) .
Catalase activity assay
Catalase activity was evaluated spectrophotometrically on 50 µg of total protein, following the consume of 5mM H 2 O 2 . Enzymatic activity was expressed as IU/mg of total protein (micromoles/min/mg of protein).
Evaluation of malondialdehyde
To assess lipid peroxidation, the malondialdehyde (MDA) concentration was evaluated, using the thiobarbituric acid reactive substances (TBARS) assay (48) . The TBARS solution contained 15% trichloroacetic acid (TCA) in 0.25 N HCl and 26mM thiobarbituricacid.To evaluate the basal concentration of MDA, 600 µl of TBARS solution was added to 50 µg of total protein dissolved in 300 µl of milliQ water. The mix was incubated for 40 min at 100°C. Afterwards, the sample was centrifuged at 14,000 rpm for 2 min and the supernatant was analyzed spectrophotometrically, at 532 nm.
Western blot analysis
Protein lysates were prepared as previously described (21) . The protein lysates were resolved on sodium dodecyl sulfate-10% or 14% polyacrylamide gels. The proteins were transferred to nitrocellulose membranes which were then incubated with Rabbit mAb anti-Phospho-AMPKα (Thr172) (clone 40H9), Rabbit mAb anti-LAMP1 (clone C54H11) and Peroxidase-conjugated goat anti-rabbit antibodies used as secondary antibodies (All: Cell Signaling Technology, Danvers, MA). Immune complexes were visualized with the use of an enhanced chemiluminescence system (Amersham International, Little Chalfont, UK) according to the manufacturer's instructions.
In vivo therapeutic studies in mice
All experiments involving animals were reviewed and approved by the licensing and ethical committee of the National Cancer Research Institute, Genoa, Italy, and by the Italian Ministry of Health.
Six-week-old female athymic Nude (nu -/nu -) mice (Envigo, Italy, S.Pietro al Natisone, Italy) were subcutaneously injected in the right flank with 1 × 10 5 B16 murine melanoma tumor cells. Mice were randomly assigned to receive 30 mg/curcumin /kg body weight or vehicle only (control mice). When tumors were palpable (tumor diameter app. 2 mm) solubilized curcumin or vehicle alone were injected into the tail vein each other day for ten days. Tumor volume was measured using a caliper and calculated using the following equation: tumor volume (mm 3 ) = (length × width × height in mm) × π/6. Body weight and general physical status of the animals were recorded daily and mice were killed by cervical dislocation after being anesthetized with xylazine (Xilor 2%, Bio98 Srl, Milan, Italy), when they showed signs of poor health.
Immunofluorescence analysis and quantification of micro-vessel density and vessel size
Histological evaluation of subcutaneous tumors was performed at the end of treatment. Briefly, tumor samples were fixed in 10% buffered-formalin solution and embedded in paraffin. For immunofluorescence analysis, 4-µm-thick sections were cut from paraffin blocks and stained with monoclonal antibodies that recognize endothelial cells, i.e. anti-CD34 (Rabbit mAb, clone EP373Y, Abcam, Milan, Italy) and α-smooth muscle actin (mouse mAbα-SMA, clone 1A4, Dako). The slides were then incubated with secondary antibodies FITC-conjugated goat antirabbit and antimouse (Abcam). Isotype-matched nonbinding mAbs were used in all antibody-staining experiments to exclude non-specificreactivity. After washing with phosphate-buffered saline, the slides were counterstained with 4,6-diamidino-2-phenylindole (DAPI; Vectashield mounting, Vector Laboratories, Burlingame, CA) and cover-slipped. Digital images were collected using a Nikon E-1000 fluorescence microscope (Nikon Instruments, Tokyo, Japan) equipped with appropriate filter sets and the Genikon imaging system software (Nikon Instruments). The percentage of CD34 and αSMA positive cells was quantified in 15 random fields from two independent experiments.
Statistical analysis
For in vitro experiments, the statistical significance of differences between experimental and control groups was assessed by unpaired t test using GraphPad Prism 3.0 software (GraphPad Software, Inc, El Camino Real, San Diego, CA). Statistical significance was considered for P values P < 0.05.
Results
Curcumin induces a fatal energetic impairment by inhibiting ATP-synthase activity, decreasing ATP generation and oxygen consumption in vitro and in vivo
Given the previous indication that curcumin inhibits the activity of the prokaryotic ATP-synthase (38), we investigated the effect of the polyphenol on a panel of murine cancer cells from different tissues. We analyzed ATP-synthase activity in isolated mitochondrial membranes from the murine B16 melanoma, CT26 colon carcinoma, 4T1 breast cancer cells and in L1210 lymphocytic leukemia cells by luminometric measurements. We observed a significant reduction of the ATP-synthase activity in all cell lines. ATP-synthase activity was reduced by 46, 36, 64 and 30% in B16, CT26, L1210 and 4T1 cells, respectively (P = 0.0006, 0.0005, 0.007, 0.0003, respectively by unpaired t-test; Figure 1A ). The inhibition of ATP-synthase activity was associated with a decrease of ATP generation by 32, 18, 35 and 46% in B16, CT26, L1210 and 4T1 cells, respectively that was significant in all cell lines except CT26 (P = 0.0007, 0.21, 0.002, 0.0007 respectively; Figure 1B) . Accordingly, the ATP/AMP ratio, a comprehensive indicator of the overall cellular energy charge, was significantly decreased by 23, 61, 21 and 36% in B16, CT26, L1210 and 4T1 cells, respectively (P = 0.0001, 0.004, 0.0002, 0.0006, respectively; Figure 1C ). As a consequence of ATP-synthase inhibition, curcumin caused a significant increase of membrane potential due to proton accumulation in all cell lines (B16 P = 0.05, CT26 P = 0.02, L1210 P = 0.02, 4T1 P = 0.004, Supplementary Figure 1 , available at Carcinogenesis Online).
Reduced ATP synthesis was accompanied by a dramatic reduction in the oxygen consumption rate of the cells as measured by an oxygen micro-respiration electrode in the presence of pyruvate/malate (P < 0.0001 for all cell lines) and succinate (P = 0.0004 for B16 cells and P < 0.0001 for CT26, L1210 e 4T1 cells; Figure 1D and E).
We also tested whether the effect of curcumin on ATP synthesis can be mimicked by inhibition of NFκB. For this purpose, we used the IkKβ specific competitive inhibitor SC-514 since curcumin has been reported to act on this kinase (49, 50) . Figure 1F shows that SC-514 had no effect on ATP synthesis in B16 cells as measured after 4 and 24 h of combined addition of SC-514 and All data are expressed as mean values ± SD. P value was calculated using unpaired t-test. *P < 0.05; **P < 0.01; ***P < 0.001. Black bars = controls; white bars = curcumin.
curcumin. B16 cells treated in parallel with curcumin showed a reduced ATP-synthesis as observed before (P = 0.0032 after 4 h and P < 0.0009 after 24 h treatment, Figure 1F ). The combination of SC-514 with curcumin did not lead to any additive effect as compared to cells treated with curcumin alone ( Figure 1F ). However, both curcumin and SC-514 significantly inhibited the expression of Bcl2, an anti-apoptotic gene whose transcription is controlled by NFκB, though apparently following different kinetics ( Figure 1G ; at 4 h SC-514 versus CTR P = 0.004 and curcumin versus CTR P < 0.0001; at 24 h SC-514 versus CTR p< 0.0001 and curcumin versus CTR P < 0.0001). The combination of curcumin and SC-514 did not show any additive effect. These data indicate that curcumin inhibits both NFκB and ATP synthase but the activity on the latter does not depend on the activity on the former.
We then investigated whether the inhibition of ATP-synthase activity observed in vitro in all four cell lines tested could also be observed in vivo. We therefore injected B16 murine melanoma cells subcutaneously in immunodeficient (nu -/nu -) mice. When tumors were palpable (tumor diameter app. 2 mm) solubilized curcumin (30 mg/kg) or vehicle alone were injected into the tail vein each other day for ten days and the tumor volume was measured using a caliper. Curcumin treated mice showed a significantly reduced tumor growth as compared to the vehicle treated animals (Figure 2A ). At the end of the experiment, tumors were removed, mitochondrial membrane fractions were prepared and analyzed for ATP-synthesis and ATP and AMP contents. ATP-synthase activity, ATP concentration and the ATP/AMP ratio were significantly reduced in the tumors of curcumin treated animals as compared to those harvested from control mice (ATP synthase activity P = 0.02; ATP concentration P < 0.0001; ATP/AMP ratio P = 0.0001; Figure 2B ) indicating that curcumin inhibits the ATP synthase also in vivo.
Anti-angiogenic effects of curcumin in vivo
Curcumin has been reported to exert anti-angiogenic effects in vitro and in vivo (9,51,52) and we therefore analyzed vessel number and size in B16 xenografts after treatment of mice with curcumin or vehicle alone using antibodies against the endothelial cell markers α-smooth muscle actin (α-SMA) and CD34-antigen (CD34). As shown in Figure 3 , curcumin caused a significant reduction of the numbers of α-SMA positive vessels per area ( Figure 3A and B P < 0.0001) and of α-SMA and CD34 positive cells per vessel ( Figure 3A-D P < 0.0001) indicating that the systemically administered polyphenol has antiangiogenic activities in B16 xenografts.
Curcumin reduces the viability of different cancer cell lines and induces tumor cell apoptosis by promoting oxidative and lipidic stress
The anti-metabolic effect of curcumin is expected to translate into reduced cell growth. We therefore analyzed the viability of our panel of tumor cells after treatment with the polyphenol. We observed 37, 28, 20 and 36% reduction in cell viability in B16, CT26, L1210 and 4T1 cells, respectively (P = 0.0001, 0.007, 0.002, 0.0007, respectively; Figure 4A ) after treatment with 10 µM curcumin for 24 h.
Cell viability appeared to be reduced as a consequence of the induction of apoptosis in these cells since curcumin treated cells showed an 83, 73, 146 and 316% increase in apoptosis over vehicle treated control cells in B16, CT26, L1210 and 4T1 cells, respectively (P = 0.003, 0.003,0.01, 0.002, respectively; Figure 4B ) after treatment with 10 µM curcumin for 24 h.
Apoptosis was likely the result of the induction of ROS in curcumin treated cells by 207, 59 and 78% in B16, CT26, and L1210 cells, respectively (P = 0.0003, 0.002, 0.004, respectively; Figure 4C ) as compared to vehicle treated controls. Similarly, MDA level, which is a marker of lipid peroxidation, was increased in curcumin treated cells compared to vehicle treated cells (37, 134 , 109 and 60% increase in B16, CT26, L1210 and 4T1 cells, P = 0.01, 0.0009,0.001, <0.0001, respectively; Figure 4D ).
Curcumin activates AMPK and induces autophagy
5'-AMP-activated protein kinase (AMPK) constitutes a major energy checkpoint in the cell (53) that we expected to be activated by the altered ATP/AMP ratio in curcumin treated cells. In fact, we observed a strong induction of AMPK phosphorylation in curcumin-treated B16 cells as compared to vehicle treated controls, as revealed by Western blots using antiphospho AMPK (pAMPK-Thr172) antibodies (180%, P = 0.0006; Figure 5A ). In order to re-establish sufficient ATP levels, pAMPK induces autophagy (54) . We measured the Microtubule Associated Protein 1 Light Chain 3 Beta (LC3B) (55) and the Lysosomal Associated Membrane Protein 1 (LAMP1) (56) as markers of autophagy. Both proteins were significantly induced in curcumin treated B16 cells as compared to vehicle treated controls (190% P = 0.01 and 150% P = 0.03 induction for LAMP1 and LC3B, respectively; Figures 5B and C) .
Curcumin alters glycolytic enzyme activities
Reduced ATP-synthesis through oxidative phosphorylation could be compensated by enhanced glycolytic activity that, though less efficient, also produces ATP (18) . The analysis of the activity of the key glycolytic enzymes including hexokinase (HK), phosphofructokinase (PFK), pyruvate kinase (PK), lactate dehydrogenase (LDH) and of the lactate levels revealed that this is not the case for CT26, L1210 and 4T1 cells, in which the latter enzyme activities are also reduced or unaltered (Table 1) . In B16 cells, on the contrary, we found an induction of all four enzyme activities as well as lactate generation indicating a partially compensatory effect in response to the inhibition of ATP synthase (Table 1) .
Discussion
The antitumoral activities of curcumin are well established in various models and mainly associated to its effect on tumor inflammation acting both on the microenvironment and on the cancer cell itself (10,57). The major mediator of these anti-inflammatory effects is NFκB, a master regulator of inflammation and apoptosis (58) . Many other signaling pathways have been described to be affected by curcumin (for review see (3)) but it is not clear to which extent these pathways are primary molecular targets of curcumin.
Growing evidence of anti-diabetic effects of curcumin (59,60) and of its influence on cell metabolism (11-17) have stimulated our interest in its potential activities on tumor metabolism. Recent studies show that the limitation of the nutrient supply to the energetically highly active tumor cells can drastically alter tumor metabolism and, as a consequence, tumor cell viability and growth (61, 62) . It has recently been postulated that curcumin acts as a calorie restriction mimetic (26) .
We therefore addressed the effects of curcumin on tumor cell metabolism focusing on ATP synthesis since the polyphenol has been shown to inhibit the ATP synthase from Escherichia coli by binding to a specific site of the F1 moiety of the complex thereby significantly increasing the catalytic dwell duration for ATP hydrolysis (40) . Effects of curcumin on the mitochondrial ATP synthase had already been reported for normal rat liver cells where it acts as a protonophore uncoupler thereby activating the FoF1-ATPase activity of the complex and leading to reduced ATP biosynthesis (38) . The consequentially increased AMP levels have been proposed to be responsible for the activation of the Unpaired t-test *P < 0.05; **P < 0.01; ***P < 0.001. master energy sensor AMPK (53) . Here, we show that curcumin consistently reduced ATP synthesis in a panel of murine tumor cells. This activity was associated with an induction of apoptosis and AMPK mediated autophagy leading to reduced tumor cell viability. The induction of apoptosis may be related to the curcumin mediated stimulation of ROS generation, which has been shown to cause endoplasmic reticulum stress in prostate cancer (63) .
Given the central role of ATP in cellular metabolism, the effect of curcumin on ATP-synthesis is likely its most important effect. Reduced ATP-synthesis appears also important for its activity as a calorie restriction mimetic. Fasting or short term starvation exerts a strong anti-Warburg effect mainly acting on the enzymes of the glycolytic pathway as revealed at both, gene and protein expression levels with consequential effects on the overall activity (21) . Similarly, curcumin decreased the activity of the key glycolytic enzymes in different tumor cells, with the only exception of murine melanoma cell line B16, in which the mitochondrial respiration (oxygen consumption and ATP synthesis) is basically low (see Figure 1) . We suggest that a further reduction of ATP synthesis in response to treatment with curcumin impairs cell viability and B16 cells try to compensate the effect of the polyphenol by increasing the activity of glycolytic enzymes. However, curcumin mimics the effects of fasting in terms of induction of phosphorylation of AMPK and the consequential increase in autophagy also in B16 cells.
The energetic impairment caused by curcumin, also observed in vivo, finally translates into reduced tumor growth. We chose an immune deficient mouse model in order to discern the direct antitumoral effects of the polyphenol from eventual effects that are mediated by an immune response. Interestingly, curcumin also shows an antiangiogenic effect in vivo that likely contributes to antitumor activity.
Several other antitumoral activities are well established for curcumin (1) . Here we focused on antimetabolic effects. Depletion of ROS-mediated DNA polymerase γ (64) might well be a consequence of reduced ATP synthase activity. Effects of curcumin on the organization of cellular microtubules have recently been reported (65) but do not appear to be related to its metabolic activities. Curcumin has been proposed to increase the activity of chemotherapy and to reduce its toxicities (66) , effects that might be linked to its inhibitory activity on the master regulator of inflammation, NFκB (67) . This activity is mediated by the inhibition of IkKβ by curcumin is well documented (9, 10) . However, the synthetic inhibitor of IkKβ, SC-514 has no effect on ATP synthesis indicating that the two activities of curcumin are independent. It is not possible to establish to which extent antimetabolic and anti-inflammatory effects of curcumin determine reduced tumor growth in vivo. In fact, tumor progression and angiogenesis, that are inhibited by curcumin, have been linked to NFκB mediated inflammation (68, 69) as well as to glucose metabolism (70) . Metabolic intervention with the anti-diabetic drug Metformin, Dichloro-dihydrofluorescein-diacetate (DCFDA) as a method to assess the level of reactive oxygen species (ROS). Data are expressed as the mean value of increase of ROS production ± SD. (D) Shows MDA levels as measured using the thiobarbituric acid reactive substance. Data are expressed as mean value ± SD from three different experiments performed. P values were calculated using unpaired t-test *P < 0.05; **P < 0.01; ***P < 0.001. Black bars = controls; white bars = curcumin.
that also has antitumoral activity, has, however, revealed paradoxical partially pro-angiogenic activities (71) . Both curcumin and Metformin act via the AMPK pathway, but curcumin also directly inhibits ATP-synthase likely affecting endothelial cell viability in a more direct way. Future studies must address the role of ATP-synthesis inhibition on angiogenesis. Although we used murine cancer cells for this study, it is highly likely that at least the anti-metabolic effects are shared by human cancer cells.
Despite decennials of research on curcumin some crucial aspects of its mechanism of action remain obscure. Especially it is unclear how the effects observed for curcumin in vitro can translate into effects in vivo given the low bioavailability, rapid degradation and elimination from the blood stream (72) . However, curcumin administered through the diet of mice has significant effects on tumor cells in the body (4-6), a fact that requires the absorption of either the compound itself or its degradation products or intestinal metabolites (73) . Here we injected curcumin directly into the caudal veins of animals in order to obviate issues linked to the bioavailability. 30mg/kg body weight correspond to 2.1 g for a human adult of 70 kg body weight. Nothing is known on i.v. injection of curcumin solutions in humans but injection of similar amounts of curcumin might be possible if suitable carriers can be found. However, it is clear that eventual applications in chemoprevention require oral administration. We used B16 murine melanoma cells, a well-established model for melanoma research (74) . We plan to address tumor inter-and intra-patient heterogeneity using patient derived xenografts in future experiments.
Curcumin has been described as pan assay interference compound (PAIN) and its biological activities have been questioned HcRed-hLC3WT plasmid and quantification of LC3B dots by fluorescence microscopy. Cells were considered positive when they showed five or more LC3B stained dots.
Each experiment was repeated two times and at least 50 transfected cells were analyzed. Data are expressed as mean value ± SD from two (LC3B) or three (LAMP1, pAMPK) different experiments performed. P value was calculated using unpaired t-test *P < 0.05; **P < 0.01; ***P < 0.001. (72) . In the this study, we present data of meticulously controlled biological assays in which curcumin shows a clear inhibitory activity on ATP synthase that alters the metabolism of the cancer cell leading to reduced growth, apoptosis and autophagy. None of our assays applied is biased by uncontrolled auto fluorescence of the compound. Despite many ill designed studies that report unreliable data on curcumin, the compound definitely has anti-cancer activities as those described here.
In conclusion, the inhibition of ATP-synthesis appears as an additional major activity of the dietary polyphenol curcumin that together with its known NFκB dependent anti-inflammatory activities controls tumor cell viability. Curcumin showed activities that are partially overlapping with those observed for short term starvation (21, 75) and can therefore be considered as a bona fide calorie restriction or fasting mimetic. The combination of anti-metabolic and anti-inflammation activities makes the compound interesting for the prevention of cancer, metabolic syndrome and other age-related disorders, eventually contributing to an extension of the lifespan (76, 77) .
Supplementary material
Supplementary material can be found at Carcinogenesis online. 
